APUS vs DDOG · $2.4M cap vs P/E 292, rev $3.43B
Apimeds Pharmaceuticals US, Inc. (APUS) versus Datadog Inc (DDOG) — a side-by-side from cached financials, not a winner call.
Apimeds Pharmaceuticals US, Inc. (APUS) is a drug manufacturers - specialty & generic company listed on US.
Datadog Inc (DDOG) is a software - application company listed on US. It is led by Olivier Pomel.
APUS does not have a complete income-statement cache yet.
Latest reported DDOG revenue for 2025-12-31 was $3.43B. Net income was $107.7M. Revenue was up 27.7% from 2024-12-31 to 2025-12-31. DDOG currently screens at market cap $47.44B and trailing P/E 292.3.
APUS currently screens at market cap $2.4M. DDOG currently screens at market cap $47.44B and trailing P/E 292.3.
Not investment advice. Open the APUS and DDOG stock pages for the full models.
Not investment advice.